AI AI ListA running list of AI company announcements

Press Release · Carl Zeiss Meditec AG

ZEISS to expand myopia solutions in China with NMPA's approval of ZEISS PT LUNANA phakic intraocular lens

Distributed by AI AI List · Originally issued via PR Newswire

ZEISS Medical Technology showcased at CIIE its next-generation aspheric phakic intraocular lens (pIOL) PT LUNANA® to address myopia in China, a growing major public health challenge for the region.

  • Research shows: China has an estimated 600 million people with myopia; a growing number are entering adulthood with myopia: roughly two in three (67.2%) people aged 15 to 19 have myopia and 9.5% have high myopia, according to a recent systematic review.1

  • China's National Medical Products Administration (NMPA) has approved ZEISS PT LUNANA, the first in the Phakic Technology (PT) family of phakic IOLs.

  • CIIE unveiling: ZEISS showcased the PT LUNANA pIOL at the 9th China International Import Expo (CIIE) in Shanghai, China.

  • In China, for Global: Prioritizing its mission to develop innovative solutions in China, the new ZEISS PT LUNANA pIOL was developed by Wuxi Carl Zeiss Vision Pro Medical Technology Co., Ltd, a joint venture of ZEISS in China, and is set to be manufactured locally.

JENA, Germany, Nov. 9, 2026 — ZEISS Medical Technology, one of the world's leading medical technology companies, announced its plans to extend ZEISS's established portfolio of solutions for addressing myopia with the recent approval from the National Medical Products Administration (NMPA) in China for the PT LUNANA® phakic IOL from ZEISS.